Does Medicare cover Wegovy?
From CMS's Part D formulary files for 2026 and 2027 plans, Medicare.gov, CMS and the FDA label. We count plans; we don't recommend one.
Short answer
Not for weight loss alone: Medicare Part D does not cover GLP-1 drugs used for weight loss.1Part D plans can cover Wegovy to lower heart attack and stroke risk in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring), with plan rules such as prior authorization.2345In CMS's formulary files, 175 of 5,496 (3.2%) Part D plans list Wegovy for 2026 and all 5,492 for 2027, every one of them with prior authorization.67For weight management, the Medicare GLP-1 Bridge covers Wegovy: if you qualify, you pay a $50 copayment for a one-month supply, through December 31, 2027.8910Why every 2027 plan lists it: Medicare's negotiated price for semaglutide starts January 1, 2027, and the law requires Part D plans to include drugs with a negotiated price in effect (see below).
Source: CMS formulary files published Sep 23, 2026 (2026 plans) and Oct 15, 2026 (2027 plans); Medicare.gov and CMS rules checked Oct 17, 2026
How many Part D plans list Wegovy
Every Medicare drug plan in CMS's file: standalone drug plans (PDP) and Medicare Advantage plans with drug coverage, including special needs plans. A plan counts when its drug list (formulary) has at least one form or strength of Wegovy. These are counts of plans, not of people enrolled in them.
| Plan year | Plans that list it | Share | Prior auth. | Quantity limit | Step therapy |
|---|---|---|---|---|---|
| 2026 | 175 of 5,496 | 3.2% | 175 | 60 | 0 |
| 2026 · injection | 175 of 5,496 | 3.2% | 175 | 50 | 0 |
| 2026 · tablet (pill) | 49 of 5,496 | 0.9% | 49 | 49 | 0 |
| 2027 | 5,492 of 5,492 | 100% | 5,492 | 5,369 | 0 |
| 2027 · injection | 5,492 of 5,492 | 100% | 5,492 | 5,355 | 0 |
| 2027 · tablet (pill) | 5,492 of 5,492 | 100% | 5,492 | 5,369 | 0 |
- 2026: standalone drug plans 0 of 367; Medicare Advantage plans with drug coverage 175 of 5,129.6
- 2027: standalone drug plans 323 of 323; Medicare Advantage plans with drug coverage 5,169 of 5,169.7
Which tier plans put it on
The lowest tier each listing plan gives Wegovy. Each plan can divide its tiers in different ways; generally, a drug in a lower tier costs you less than one in a higher tier.11 Your cost depends on your plan.
| Plan year | Tier 1 | Tier 2 | Tier 3 | Tier 4 | Tier 5 | Tier 6 |
|---|---|---|---|---|---|---|
| 2026 | 17 | 1 | 125 | 10 | 22 | 0 |
| 2027 | 123 | 313 | 5,056 | 0 | 0 | 0 |
Why every 2027 Part D plan lists Wegovy
Semaglutide, sold as Ozempic, Rybelsus and Wegovy, is one of the drugs Medicare negotiated a price for. From January 1, 2027, the negotiated price is $274 for a 30-day supply ($959 list price in 2024, 71% lower); for a box of four Wegovy 2.4 mg pens (NDC 00169-4524-14) CMS gives $385.63.121314 CMS's fact sheet on those prices says:
“As required by law, Medicare prescription drug plans, including standalone Part D plans and Medicare Advantage-prescription drug plans, must include in their formularies the selected drugs for which CMS and the participating drug company have agreed to a negotiated price.”
- The law is section 1860D-4(b)(3)(I) of the Social Security Act, added by the Inflation Reduction Act: from 2026 on, Part D plans must include each selected drug whose negotiated price is in effect that year.15 CMS applies it for 2026 through 2028 through guidance.16 A final rule published in the Federal Register on Nov 9, 2026 (91 FR 72176) writes it into the regulations at 42 CFR 423.120(b)(2)(vii), applying to Part D coverage from Jan 1, 2029.1718
- CMS's formulary files show the change: 175 of 5,496 plans (3.2%) list Wegovy for 2026, before the price takes effect, and all 5,492 for 2027.67 Citable version, with the method and a CSV: Wegovy goes from 3% to 100% of Medicare Part D plans in 2027.
- On the list is not coverage for weight loss. Part D does not cover GLP-1 drugs used for weight loss;1 plans cover Wegovy for the uses listed below, under their own rules.
- Plans still set the terms. In the same rule CMS says: "At this time, we are not imposing tier placement, utilization management, or other special formulary requirements for selected drugs."19 CMS says this leaves plans the flexibility to keep managing costs through utilization management.20 In the 2027 files, every plan that lists Wegovy requires prior authorization, and plans put it on tier 1 (123 plans), tier 2 (313) or tier 3 (5,056).7
- The $274 is the price the drug company must make available to pharmacies for people with Medicare, not what you pay; your cost depends on your plan.21
By state
Each cell: the share of the state's Part D plans that list Wegovy, and the count. A plan counts in every state where it is sold. Medicare Advantage plans are sold by county, so a state's number includes plans sold in only part of the state. To see the plans for your ZIP code and your drugs, use Medicare Plan Finder; before joining a plan, Medicare.gov says to review its formulary to check if it covers the drugs you take.22
| State | 2026 plans | 2027 plans |
|---|---|---|
| Alabama | 0% 0 of 102 | 100% 115 of 115 |
| Alaska | 0% 0 of 9 | 100% 9 of 9 |
| Arizona | 0% 0 of 136 | 100% 148 of 148 |
| Arkansas | 0% 0 of 93 | 100% 86 of 86 |
| California | 13.1% 52 of 397 | 100% 397 of 397 |
| Colorado | 13.2% 14 of 106 | 100% 106 of 106 |
| Connecticut | 0% 0 of 53 | 100% 54 of 54 |
| Delaware | 4.8% 2 of 42 | 100% 43 of 43 |
| District of Columbia | 12.0% 3 of 25 | 100% 21 of 21 |
| Florida | 1.8% 11 of 597 | 100% 549 of 549 |
| Georgia | 5.2% 8 of 154 | 100% 151 of 151 |
| Hawaii | 13.0% 6 of 46 | 100% 50 of 50 |
| Idaho | 0% 0 of 50 | 100% 45 of 45 |
| Illinois | 0% 0 of 150 | 100% 133 of 133 |
| Indiana | 0% 0 of 128 | 100% 140 of 140 |
| Iowa | 0% 0 of 65 | 100% 64 of 64 |
| Kansas | 0% 0 of 89 | 100% 84 of 84 |
| Kentucky | 0% 0 of 115 | 100% 123 of 123 |
| Louisiana | 0.9% 1 of 114 | 100% 126 of 126 |
| Maine | 0% 0 of 54 | 100% 52 of 52 |
| Maryland | 15.9% 10 of 63 | 100% 49 of 49 |
| Massachusetts | 8.3% 8 of 96 | 100% 89 of 89 |
| Michigan | 0.5% 1 of 190 | 100% 183 of 183 |
| Minnesota | 2.5% 2 of 80 | 100% 63 of 63 |
| Mississippi | 0% 0 of 96 | 100% 105 of 105 |
| Missouri | 0% 0 of 155 | 100% 171 of 171 |
| Montana | 0% 0 of 36 | 100% 27 of 27 |
| Nebraska | 0% 0 of 55 | 100% 51 of 51 |
| Nevada | 0% 0 of 110 | 100% 100 of 100 |
| New Hampshire | 0% 0 of 25 | 100% 25 of 25 |
| New Jersey | 0% 0 of 85 | 100% 74 of 74 |
| New Mexico | 0% 0 of 78 | 100% 68 of 68 |
| New York | 1.5% 3 of 202 | 100% 215 of 215 |
| North Carolina | 1.7% 3 of 173 | 100% 177 of 177 |
| North Dakota | 0% 0 of 33 | 100% 26 of 26 |
| Ohio | 0% 0 of 205 | 100% 173 of 173 |
| Oklahoma | 0% 0 of 82 | 100% 81 of 81 |
| Oregon | 4.1% 4 of 97 | 100% 92 of 92 |
| Pennsylvania | 0.6% 2 of 319 | 100% 324 of 324 |
| Rhode Island | 0% 0 of 31 | 100% 29 of 29 |
| South Carolina | 1.1% 1 of 93 | 100% 91 of 91 |
| South Dakota | 0% 0 of 30 | 100% 30 of 30 |
| Tennessee | 0% 0 of 135 | 100% 157 of 157 |
| Texas | 0% 0 of 407 | 100% 412 of 412 |
| Utah | 0% 0 of 58 | 100% 53 of 53 |
| Vermont | 0% 0 of 13 | 100% 14 of 14 |
| Virginia | 4.3% 6 of 138 | 100% 145 of 145 |
| Washington | 15.2% 19 of 125 | 100% 114 of 114 |
| West Virginia | 0% 0 of 72 | 100% 70 of 70 |
| Wisconsin | 0% 0 of 99 | 100% 97 of 97 |
| Wyoming | 0% 0 of 19 | 100% 13 of 13 |
| Puerto Rico | 33.8% 22 of 65 | 100% 64 of 64 |
| Virgin Islands | 0% 0 of 1 | 100% 1 of 1 |
| Guam | 0% 0 of 1 | 100% 1 of 1 |
| American Samoa | 0% 0 of 1 | 100% 1 of 1 |
| Northern Mariana Islands | 0% 0 of 1 | 100% 1 of 1 |
What a plan's drug list, tiers, prior authorization, quantity limits, step therapy and exceptions mean, for every Part D drug: "On the plan's drug list," explained · what Part D costs (deductible, out-of-pocket limit, Extra Help): Part D costs · denied? how to appeal, with your deadlines (including Wegovy prescribed to lower heart risk).
Uses Part D can cover
The FDA label's uses for Wegovy other than weight loss:
- to lower the risk of heart attack, stroke or death from heart disease in adults with established heart disease and either obesity or overweight.4
- to treat MASH, a fatty liver disease, with moderate to advanced liver scarring (fibrosis) in adults.5
For these uses, CMS says your prescriber completes the Part D plan's own requirements, such as prior authorization.3
For weight management: the Medicare GLP-1 Bridge
Both Wegovy forms are on the Medicare GLP-1 Bridge list: the injection and the tablet.8 If you qualify, you pay a $50 copayment to the pharmacy for a one-month supply, through December 31, 2027.910 Who qualifies, how to get it and how it works with Part D (the same for every Bridge drug): the Medicare GLP-1 Bridge, in full.
The maker's self-pay price
The lowest listed price is shown, with its strength; your prescriber decides the strength. Click a form for every strength.
| Form | Lowest listed self-pay price | On the Bridge list |
|---|---|---|
| Wegovy Prefilled pen (injection) | $349 / month 0.25 mg24 | Yes |
| Wegovy Tablet | $149 / month 1.5 mg25 | Yes |
- Buying with TrumpRx or another discount card instead of your Medicare plan does not count toward your Medicare deductible or out-of-pocket maximum.23 Using TrumpRx with Medicare
How we counted
- From CMS's "Monthly Prescription Drug Plan Formulary and Pharmacy Network Information" files on data.cms.gov: the 2026 file published Sep 23, 2026 (5,496 plans) and the 2027 file published Oct 15, 2026 (5,492 plans).67 Plans CMS marks as suppressed are left out.
- Drugs are matched by RxNorm code (NLM RxNav), and every matched line is checked against the FDA NDC Directory; Ozempic includes Ozempic tablets and the Rybelsus name. Our archived copy of each CMS file has a SHA-256 fingerprint, and the counts are rebuilt from it on every data update.
- Download every count by drug, year, form and state: Medicare Part D GLP-1 Formulary Coverage by State.
- Have a plan already? Read your plan's drug list PDF to see how it lists Wegovy. Enrollment dates: GLP-1 deadlines calendar.
How this page is kept current
- CMS and Medicare.gov pages and fact sheets: archived daily.
- CMS Part D formulary files (which plans list which drugs): CMS publishes a new file monthly; we check for one weekly (Wednesdays). A person downloads and archives the new file, and the plan counts change when we rebuild from it.
- Every change in an archived copy is flagged for a person to check against the official page; the site is updated only after that check. Nothing is published automatically. Changes: price change log · mistakes: corrections · all sources: sources and update schedule.
Helping clients? Free printable handouts: Medicare Part D and GLP-1s in your state (pick a state) (español) · Medicare GLP-1 Bridge: who qualifies, cost, dates (español) · for professionals.
Free help from a person
- SHIP (State Health Insurance Assistance Program): free, one-on-one Medicare counseling from a national government program with a SHIP in every state.29 SHIP counselors help you choose a plan, review coverage, understand costs, apply for Extra Help, and file a complaint or an appeal. Find your SHIP.2728
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048, 24 hours a day, 7 days a week (except some federal holidays), or live chat on Medicare.gov.26
We list only government and government-funded programs. We take no money from anyone listed here, and we do not pass your details to anyone.
Which drug, which dose, and whether to start, stop or switch are medical decisions. Ask your doctor or pharmacist.
Other Medicare questions
- Does Medicare cover Zepbound?
- Does Medicare cover Ozempic?
- Does Medicare cover Mounjaro?
- Does Medicare cover Foundayo?
- Can you use TrumpRx with Medicare?
- IRMAA: Part D premiums at higher incomes
- The Medicare GLP-1 Bridge, in full
Official sources for this page (29)
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”
CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors · as of Oct 17, 2026“For example, beneficiaries prescribed Zepbound® for the treatment of moderate to severe obstructive sleep apnea in adults with obesity or Wegovy® to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight should continue to receive coverage through Medicare Part D.”
CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors · as of Oct 17, 2026“When a provider prescribes a GLP-1 drug for a beneficiary for a use covered under the basic Part D benefit (e.g. Zepbound® for the treatment of moderate to severe obstructive sleep apnea in adults with obesity; Wegovy® to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight) the provider will need to complete the applicable utilization management requirements through the beneficiary’s Part D plan.”
CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors · as of Oct 17, 2026“to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight.”
FDA label (DailyMed), 1 INDICATIONS AND USAGE, version 19 (Jun 30, 2026) · as of Oct 17, 2026“for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) in adults.”
FDA label (DailyMed), 1 INDICATIONS AND USAGE, version 19 (Jun 30, 2026) · as of Oct 17, 2026“Starting July 1, 2026, Medicare covers these GLP-1 drugs: Foundayo® (tablet) Wegovy® (injection or tablet) Zepbound® (KwikPen® only. The program doesn’t cover single-dose Zepbound® vials or pens).”
Medicare.gov: Weight loss drugs · as of Nov 5, 2026“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
Medicare.gov: Weight loss drugs · as of Nov 5, 2026“The Centers for Medicare & Medicaid Services (CMS) is extending the Medicare GLP-1 Bridge through December 31, 2027.”
CMS HPMS memo, April 21, 2026 · as of Oct 17, 2026“Each plan can divide its tiers in different ways. Generally, a drug in a lower tier will cost you less than a drug in a higher tier.”
Medicare.gov: How do drug plans work? · as of Nov 15, 2026“Ozempic; Rybelsus; Wegovy Novo Nordisk Inc. Type 2 diabetes; Type 2 diabetes and cardiovascular disease; Cardiovascular disease and obesity/ overweight $274 $959 71% $15,161,908,000 2,282,000”
“00169-4524-14 2.4 mg /0.75 mL Pen, 4 Pens (Wegovy) $385.63”
“These negotiated prices will become effective on January 1, 2027.”
“Section 11001(b) of the IRA added section 1860D-4(b)(3)(I)(i) of the Act to require that for 2026 and each subsequent year, Part D plans include each covered Part D drug that is a selected drug under section 1192 of the Act on Part D formularies if an MFP is in effect for that drug with respect to that year.”
“For 2026, 2027, and 2028, we have implemented this requirement through guidance.”
“(vii) Except as specified in paragraph (b)(2)(viii) of this section, for 2026 and each subsequent year, include each Part D drug that is a selected drug under section 1192 of the Act for which a maximum fair price (as defined in section 1191(c)(3) of the Act) is in effect with respect to the year.”
“Applicability date: These regulations are applicable to the Negotiation Program beginning with respect to initial price applicability year 2029 and to Part D Program coverage beginning January 1, 2029.”
“At this time, we are not imposing tier placement, utilization management, or other special formulary requirements for selected drugs.”
“we believe our current approach provides Part D plan sponsors with the flexibility to continue to manage costs through utilization management in a clinically appropriate manner, while allowing us to monitor practices that may undermine beneficiary access to selected drugs and potentially inform new requirements for future contract years.”
“A participating drug company with a selected drug is required to ensure the negotiated price is made available to eligible individuals and to the pharmacies, mail-order services, and other entities that dispense the selected drug with respect to such individuals.”
“Before joining a plan, be sure to review its formulary to check if it covers the drugs you take.”
Medicare.gov: How do drug plans work? · as of Nov 15, 2026“TrumpRx and other types of discount cards aren’t considered creditable coverage. When you use them (instead of your Medicare plan) to buy drugs, it doesn’t count toward your Medicare deductible or out-of-pocket maximum.”
Medicare.gov: Weight loss drugs · as of Nov 5, 2026“Limited Time Offer – New patients pay $199* for the first two monthly fills of Wegovy® (semaglutide) injection 0.25mg and 0.5mg, then $349/month. Only available for 2 monthly fills between 11/17/2025- 12/31/2026. For each fill after, pay $349/month for Wegovy® 0.25mg, 0.5mg, 1mg, 1.7mg, or 2.4mg and $399/month for Wegovy® HD 7.2mg.”
TrumpRx.gov: Wegovy Prefilled pen (injection) listing · as of Oct 17, 2026“Self-pay pricing varies by dose. Eligibility and restrictions apply. Government beneficiaries excluded. One month is defined as one bottle containing 30 tablets. Novo Nordisk reserves the right to modify or cancel this offer at any time. See full Terms and Conditions.”
TrumpRx.gov: Wegovy Tablet listing · as of Oct 17, 2026“You can talk or live chat with a real person, 24 hours a day, 7 days a week (except some federal holidays.) 1-800-MEDICARE (1-800-633-4227) TTY users can call 1-877-486-2048”
Medicare.gov: Talk to someone · as of Oct 30, 2026“Get free health insurance counseling State Health Insurance Assistance Programs (SHIPs) help people with Medicare and their families: Choose a plan Review coverage Understand costs Apply for Extra Help File a complaint or an appeal”
Medicare.gov: Talk to someone · as of Oct 30, 2026“SHIP is a national program that offers one-on-one assistance, counseling, and education to Medicare beneficiaries, their families, and caregivers to help them make informed decisions about their care and benefits.”
ACL: State Health Insurance Assistance Program (SHIP) · as of Nov 14, 2026“There are 54 SHIP grantees (one in each of the 50 states, Puerto Rico, Guam, the District of Columbia, and the U.S. Virgin Islands).”
ACL: State Health Insurance Assistance Program (SHIP) · as of Nov 14, 2026